Valved Graft Post-Market Clinical Follow-up Study

Abbott Medical Devices

Summary

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement Exclusion Criteria: * anticoagulation therapy intolerant * active endocarditis * anatomical or medical, surgical, psychological or social contraindications

Interventions

Device
VAVGJ
Replacement of the aortic valve and ascending aorta
Device
CAVGJ
Replacement of the aortic valve and ascending aorta

Locations (25)

University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama
University of Michigan
Ann Arbor, Michigan
Mission Health & Hospitals
Asheville, North Carolina
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Klinik Floridsdorf
Vienna